Given the highly positive immunostaining of TCL1b in human angiosarcoma and various human cancer tissues, it is plausible that TCL1b can serve as a putative molecular target for neoplastic diseases in general, in particular targeting angiosarcoma in humans. The gene discussed is TCL1B; the disease is cancer.